Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(22%)
Results Posted
67%(2 trials)

Phase Distribution

Ph phase_2
2
22%
Ph phase_1
2
22%
Ph phase_3
1
11%
Ph phase_4
3
33%

Phase Distribution

2

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(3)
Other(2)

Detailed Status

Completed3
unknown2
Not yet recruiting2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (25.0%)
Phase 22 (25.0%)
Phase 31 (12.5%)
Phase 43 (37.5%)

Trials by Status

unknown222%
completed333%
not_yet_recruiting222%
recruiting222%

Recent Activity

2 active trials
Showing 5 of 9
recruitingphase_3

Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue

NCT06905587
not_yet_recruitingphase_1

A Multimodal Imaging Study of Dopamine in Early Psychosis

NCT06977308
not_yet_recruitingphase_4

Treating Young Children With Attention Deficit Hyperactivity Disorder

NCT07300956
recruitingphase_2

Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia

NCT07279740
completedphase_4

Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder

NCT00429273
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT06905587Phase 3

Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue

Recruiting
NCT06977308Phase 1

A Multimodal Imaging Study of Dopamine in Early Psychosis

Not Yet Recruiting
NCT07300956Phase 4

Treating Young Children With Attention Deficit Hyperactivity Disorder

Not Yet Recruiting
NCT07279740Phase 2

Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia

Recruiting
NCT00429273Phase 4

Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder

Completed
NCT02430896

Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD

Unknown
NCT00602290Phase 4

Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With Depression

Completed
NCT02778360Phase 1

Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder

Unknown
NCT02695355Phase 2

ERP Based Single-dose Predictions of Stimulants

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9